This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Kee Song Bio-Technology Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Kee Song Bio-Technology Holdings.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Food Gewinnwachstum	19.7%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Mar 15

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Nov 30

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da Kee Song Bio-Technology Holdings jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

TPEX:1258 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (TWD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2023	2,698	130	269	321	N/A
12/31/2022	2,571	95	204	254	N/A
9/30/2022	2,446	61	167	200	N/A
6/30/2022	2,406	99	254	291	N/A
3/31/2022	2,318	76	204	233	N/A
12/31/2021	2,289	74	203	228	N/A
9/30/2021	2,267	12	166	199	N/A
6/30/2021	2,331	48	146	178	N/A
3/31/2021	2,401	57	150	184	N/A
12/31/2020	2,545	-16	119	158	N/A
9/30/2020	2,721	-56	72	90	N/A
6/30/2020	2,913	-90	-54	5	N/A
3/31/2020	2,978	-167	-170	-17	N/A
12/31/2019	3,039	-125	-237	-67	N/A
9/30/2019	3,005	-97	-310	3	N/A
6/30/2019	2,907	-216	-365	-13	N/A
3/31/2019	2,940	-170	-400	29	N/A
12/31/2018	2,835	-149	-468	74	N/A
9/30/2018	2,702	-124	-523	15	N/A
6/30/2018	2,662	9	-381	53	N/A
3/31/2018	2,553	26	-258	78	N/A
12/31/2017	2,481	46	-662	89	N/A
9/30/2017	2,467	68	-663	90	N/A
6/30/2017	2,448	107	-703	102	N/A
3/31/2017	2,433	122	-677	85	N/A
12/31/2016	2,436	136	N/A	123	N/A
9/30/2016	2,391	142	N/A	317	N/A
6/30/2016	2,302	141	N/A	326	N/A
3/31/2016	2,121	139	N/A	262	N/A
12/31/2015	1,837	129	N/A	244	N/A
9/30/2015	1,644	134	N/A	123	N/A
6/30/2015	1,416	105	N/A	111	N/A
3/31/2015	1,304	99	N/A	149	N/A
12/31/2014	1,309	93	N/A	134	N/A
9/30/2014	1,289	88	N/A	122	N/A
6/30/2014	1,278	84	N/A	130	N/A
3/31/2014	1,264	71	N/A	102	N/A
12/31/2013	1,259	58	N/A	77	N/A
9/30/2013	1,278	50	N/A	-17	N/A
6/30/2013	1,299	53	N/A	41	N/A
3/31/2013	1,323	67	N/A	88	N/A
12/31/2012	1,343	88	N/A	128	N/A
9/30/2012	1,338	92	N/A	118	N/A
6/30/2012	1,329	96	N/A	133	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Insufficient data to determine if 1258's forecast earnings growth is above the savings rate (0.8%).

Ertrag vs. Markt: Insufficient data to determine if 1258's earnings are forecast to grow faster than the TW market

Hohe Wachstumserträge: Insufficient data to determine if 1258's earnings are expected to grow significantly over the next 3 years.

Einnahmen vs. Markt: Insufficient data to determine if 1258's revenue is forecast to grow faster than the TW market.

Hohe Wachstumseinnahmen: Insufficient data to determine if 1258's revenue is forecast to grow faster than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Insufficient data to determine if 1258's Return on Equity is forecast to be high in 3 years time

This company listing is no longer active

Kee Song Bio-Technology Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

First quarter 2023 earnings released: EPS: NT$1.46 (vs NT$0.51 in 1Q 2022)

Full year 2022 earnings released: EPS: NT$2.57 (vs NT$2.00 in FY 2021)

Third quarter 2022 earnings released: NT$1.29 loss per share (vs NT$0.25 loss in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: NT$1.30 (vs NT$0.67 in 2Q 2021)

Kee Song Bio-Technology Holdings Limited Announces Directors Elections

Kee Song Bio-Technology Holdings Limited Announces General Manager Changes

Kee Song Bio-Technology Holdings Limited Announces Board Changes

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: NT$0.51 (vs NT$0.45 in 1Q 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: NT$0.24 loss per share (vs NT$0.74 profit in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS NT$0.66 (vs NT$0.92 in 2Q 2020)

First quarter 2021 earnings released: EPS NT$0.45 (vs NT$1.54 loss in 1Q 2020)

Full year 2020 earnings released: NT$0.43 loss per share (vs NT$3.39 loss in FY 2019)

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

New 90-day high: NT$18.25

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Third quarter 2020 earnings released: EPS NT$0.74

New 90-day high: NT$14.90

First half earnings released

New 90-day high - NT$13.85

First half earnings released

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken